Shenyang Xingqi Pharmaceutical Co Ltd Strategic Asset Allocation Index
Shenyang Xingqi Pharmaceutical Co Ltd strategic asset allocation index. Shenyang Xingqi Pharmaceutical Co Ltd (300573) has a Strategic Asset Allocation Index of 47.6% as of June 2023. Strategic assets (PP&E of CN¥751.47 Million plus long-term investments of CN¥-) total CN¥751.47 Million, measured against net assets of CN¥1.58 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 300573 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shenyang Xingqi Pharmaceutical Co Ltd (2011–2022)
Strategic asset allocation index of Shenyang Xingqi Pharmaceutical Co Ltd from 2011 to 2022. This chart shows how Shenyang Xingqi Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of June 2023, the index stands at 47.6%, representing strategic assets of CN¥751.47 Million against net assets of CN¥1.58 Billion CNY. Check Shenyang Xingqi Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Shenyang Xingqi Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2011–2022)
Shenyang Xingqi Pharmaceutical Co Ltd strategic asset allocation index by year from 2011 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Shenyang Xingqi Pharmaceutical Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shenyang Xingqi Pharmaceutical Co Ltd (300573) total market value.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 44.8% | CN¥695.92 Million | CN¥695.92 Million | CN¥- | CN¥1.55 Billion | ▲ +4.0 pp |
| 2021 | 40.8% | CN¥548.60 Million | CN¥548.60 Million | CN¥- | CN¥1.34 Billion | ▼ -35.3 pp |
| 2020 | 76.1% | CN¥527.90 Million | CN¥527.90 Million | CN¥- | CN¥694.06 Million | ▼ -6.4 pp |
| 2019 | 82.5% | CN¥474.25 Million | CN¥474.25 Million | CN¥- | CN¥574.90 Million | ▲ +5.5 pp |
| 2018 | 77.0% | CN¥427.22 Million | CN¥425.03 Million | CN¥2.20 Million | CN¥554.58 Million | ▼ -1.2 pp |
| 2017 | 78.2% | CN¥433.02 Million | CN¥430.83 Million | CN¥2.20 Million | CN¥553.38 Million | ▼ -6.8 pp |
| 2016 | 85.1% | CN¥443.20 Million | CN¥443.20 Million | CN¥- | CN¥520.95 Million | ▼ -37.7 pp |
| 2015 | 122.8% | CN¥478.65 Million | CN¥478.15 Million | CN¥500.00K | CN¥389.79 Million | ▼ -11.3 pp |
| 2014 | 134.1% | CN¥493.27 Million | CN¥493.27 Million | CN¥- | CN¥367.81 Million | ▲ +17.4 pp |
| 2013 | 116.7% | CN¥393.07 Million | CN¥393.07 Million | CN¥- | CN¥336.80 Million | ▲ +53.5 pp |
| 2012 | 63.2% | CN¥183.86 Million | CN¥183.86 Million | CN¥- | CN¥290.70 Million | ▲ +41.1 pp |
| 2011 | 22.2% | CN¥54.79 Million | CN¥54.79 Million | CN¥- | CN¥247.00 Million | — |